Cara Therapeutics
CARA
#10952
Rank
C$11.63 M
Marketcap
C$7.63
Share price
-2.56%
Change (1 day)
20.23%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): C-$28.28

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$30.11. In 2023 the company made an earnings per share (EPS) of C-$37.51 a decrease over its 2022 EPS that were of C-$27.36.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$28.28-24.61%
2023C-$37.5137.11%
2022C-$27.36-8.09%
2021C-$29.77
2019C-$42.8520.87%
2018C-$35.457.85%
2017C-$32.87-9.05%
2016C-$36.14110%
2015C-$17.2117.65%
2014C-$14.63-3.42%
2013C-$15.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58-131.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-103.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
C-$49.82 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C-$72.14 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
C-$3.20-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA